Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AX Other antihistamines for systemic use
R06AX13 Loratadine
D00364 Loratadine (JAN/USP/INN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
44 Allergic agents
449 Miscellaneous
4490 Miscellaneous
D00364 Loratadine (JAN/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Loratadine
D00364 Loratadine (JAN/USP/INN)
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
D00364 Loratadine
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
D00364 Loratadine
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D00364 Loratadine
Drug classes [BR:br08332]
Anti-allergic agent
DG01482 Histamine receptor H1 antagonist
D00364 Loratadine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH1
D00364 Loratadine (JAN/USP/INN) <JP/US>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00364
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00364
Rx-to-OTC switch list in the USA [br08315.html]
D00364
Rx-to-OTC switch list in Japan [br08314.html]
D00364